Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
Can Liver J ; 7(2): 255-256, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38746862
2.
Can Liver J ; 7(1): 1-2, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38505783
3.
Can Liver J ; 6(4): 373-374, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38152321
4.
Can Liver J ; 6(3): 291-294, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-38020193
5.
Can Liver J ; 6(1): 1, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36908572
6.
Can Liver J ; 5(3): 435-436, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36133899
7.
Can Liver J ; 5(3): 327-328, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36133903
8.
Can Liver J ; 5(3): 424-427, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-36133905

RESUMEN

In this article, we report on a 62-year-old non-cirrhotic male presenting to the emergency department (ED) with chronic abdominal pain, anorexia, and weight loss. Upon initial presentation, physical exam was unremarkable, other than for sarcopenia and splenomegaly. Initial imaging studies revealed a large thrombosis from the iliac vein to the right atrium of the heart. Following discharge, the patient re-consulted to the ED four months later and was re-admitted in renal failure and ascites. The diagnosis of Budd-Chiari syndrome (BCS) was established. Positive immunohistochemistry confirmed a neoplastic ideology of epithelial nature. This case offers a unique perspective on the clinical presentation of secondary BCS, necessitating a consideration in the differential diagnosis of a para-vascular cause. In this case, chronic abdominal pain, often overlooked, may necessitate further workup to establish a clinical diagnosis.

9.
Can Liver J ; 5(1): 96-100, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35990789

RESUMEN

Notwithstanding the groundbreaking achievement of hepatitis C curative treatment with direct-acting antiviral therapies, Canada faces an uphill battle in reaching the 2030 goal of viral elimination set forth by the World Health Organization, a goal made more difficult by the COVID-19 pandemic. There is limited understanding of the diagnostic and treatment barriers, and challenges in linkage to care in Canada, especially as it pertains to primary care providers in a community context. Therefore, in this article, the authors conducted a survey study to evaluate the following factors: primary care providers' knowledge of specialist treatment options and the importance of screening and treatment; and patient factors, including transportation, linguistic barriers, and other socio-economic status indicators that impact the screening and management of hepatitis C. The results suggest that public health campaigns that protocolize and/or incentivize screening and referrals may provide solutions to addressing such barriers.

11.
Can Liver J ; 5(2): 101-102, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35991482
12.
Can Liver J ; 5(4): 439-440, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38144404
13.
Can Liver J ; 5(4): 437-438, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38144410
17.
Can Liver J ; 3(2): 163-164, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-35991854
20.
Transplant Proc ; 51(10): 3330-3337, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31732200

RESUMEN

BACKGROUND AND AIMS: Frailty is associated with increased morbidity and mortality, and this is tightly linked to liver decompensation and increased complication rates among liver transplant (LT) candidates. The aim of the study was to evaluate the efficacy of a structured in- and outpatient exercise training program for cirrhotic patients who were referred for liver transplant evaluation. METHODS: We retrospectively reviewed 458 consecutive LT patients. There were 200 patients who underwent LT prior to the implementation of an exercise training program (non-ETP) and 258 LT patients who underwent a comprehensive exercise training program (ETP). Baseline characteristics, readmission rate, and length of hospital stay (LOS) were analyzed and compared between the 2 groups. RESULTS: The ETP group were more likely to have diabetes mellitus and coronary artery disease. However, there was no significant difference in the postoperative complication rates between the 2 groups except for more infections in the ETP group compared to the non-ETP group. There was a trend toward lower 90-day readmission rate in the ETP group (17.9% vs 20%) and shorter LOS (14 vs 17 days). CONCLUSION: There was a trend toward reduced 90-day readmission and shorter length of stay after implementation of an exercise training program.


Asunto(s)
Terapia por Ejercicio/estadística & datos numéricos , Fibrosis/terapia , Trasplante de Hígado/rehabilitación , Anciano , Terapia por Ejercicio/métodos , Femenino , Humanos , Tiempo de Internación/estadística & datos numéricos , Trasplante de Hígado/efectos adversos , Trasplante de Hígado/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Readmisión del Paciente/estadística & datos numéricos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Periodo Preoperatorio , Estudios Retrospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA